568 related articles for article (PubMed ID: 16903847)
1. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
[TBL] [Abstract][Full Text] [Related]
2. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
Hahn M; Timmer M; Nikkhah G
J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
[TBL] [Abstract][Full Text] [Related]
3. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
[TBL] [Abstract][Full Text] [Related]
4. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
5. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
6. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
[TBL] [Abstract][Full Text] [Related]
7. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
8. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
Sajadi A; Bensadoun JC; Schneider BL; Lo Bianco C; Aebischer P
Neurobiol Dis; 2006 Apr; 22(1):119-29. PubMed ID: 16300956
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
Baker KA; Sadi D; Hong M; Mendez I
J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
Krobert K; Lopez-Colberg I; Cunningham LA
Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
[TBL] [Abstract][Full Text] [Related]
12. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
13. Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain.
Thompson LH; Kirik D; Björklund A
Exp Neurol; 2008 Sep; 213(1):220-8. PubMed ID: 18602916
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
Inden M; Kim DH; Qi M; Kitamura Y; Yanagisawa D; Nishimura K; Tsuchiya D; Takata K; Hayashi K; Taniguchi T; Yoshimoto K; Shimohama S; Sumi S; Inoue K
Neurosci Lett; 2005 Oct; 387(3):151-6. PubMed ID: 16023291
[TBL] [Abstract][Full Text] [Related]
15. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
[TBL] [Abstract][Full Text] [Related]
16. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
[TBL] [Abstract][Full Text] [Related]
17. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
18. GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease.
Wang F; Kameda M; Yasuhara T; Tajiri N; Kikuchi Y; Liang HB; Tayra JT; Shinko A; Wakamori T; Agari T; Date I
Neurosci Res; 2011 Sep; 71(1):92-8. PubMed ID: 21699926
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
20. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]